HYDRATANT ANTI-ÂGE RÉÉQUILIBRANT À LARGE SPECTRE FPS 30 | PA+++ Lotion Canada - français - Health Canada

hydratant anti-âge rééquilibrant à large spectre fps 30 | pa+++ lotion

murad llc - homosalate; octisalate; avobenzone; octocrilène - lotion - 4%; 4%; 2%; 2% - homosalate 4%; octisalate 4%; avobenzone 2%; octocrilène 2% - sunscreen agents

HYDRATANT ANTI-ÂGE À LARGE SPECTRE FPS 30 | PA+++ Lotion Canada - français - Health Canada

hydratant anti-âge à large spectre fps 30 | pa+++ lotion

murad llc - homosalate; octisalate; avobenzone; octinoxate - lotion - 8%; 5%; 3%; 7.5% - homosalate 8%; octisalate 5%; avobenzone 3%; octinoxate 7.5% - sunscreen agents

PERFECTING DAY CREAM BROAD SPECTRUM SPF 30 PA +++ Crème Canada - français - Health Canada

perfecting day cream broad spectrum spf 30 pa +++ crème

murad llc - octinoxate; oxybenzone; homosalate; octisalate; avobenzone - crème - 7.5%; 4.0%; 6.5%; 5.0%; 2.0% - octinoxate 7.5%; oxybenzone 4.0%; homosalate 6.5%; octisalate 5.0%; avobenzone 2.0% - sunscreen agents

SHEER LUSTRE DAY MOISTURE BROAD SPECTRUM SPF 15 PA+++ Lotion Canada - français - Health Canada

sheer lustre day moisture broad spectrum spf 15 pa+++ lotion

murad llc - avobenzone; octinoxate; oxybenzone - lotion - 2.0%; 7.5%; 2.0% - avobenzone 2.0%; octinoxate 7.5%; oxybenzone 2.0% - sunscreen agents

OIL AND PORE CONTROL MATTIFIER BROAD SPECTRUM SPF 45 Lotion Canada - français - Health Canada

oil and pore control mattifier broad spectrum spf 45 lotion

murad llc - homosalate; octisalate; octocrilène; avobenzone - lotion - 10%; 5%; 5%; 3% - homosalate 10%; octisalate 5%; octocrilène 5%; avobenzone 3% - sunscreen agents

PegIntron 50 Mikrogramm Injektionspräparat Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

pegintron 50 mikrogramm injektionspräparat

msd merck sharp & dohme ag - peginterferonum alfa-2b - injektionspräparat - praeparatio cryodesiccata: peginterferonum alfa-2b 50 µg, dinatrii phosphas, natrii dihydrogenophosphas dihydricus, saccharum, polysorbatum 80, pro vitro. solvens: aqua ad iniectabilia, q.s. ad solutionem pro 0.5 ml pro vitro. - chronische hepatitis c - biotechnologika

PegIntron Pen 50 Mikrogramm Injektionspräparat Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

pegintron pen 50 mikrogramm injektionspräparat

msd merck sharp & dohme ag - peginterferonum alfa-2b - injektionspräparat - praeparatio cryodesiccata: peginterferonum alfa-2b 50 µg, dinatrii phosphas, natrii dihydrogenophosphas dihydricus, saccharum, polysorbatum 80. solvens: aqua ad iniectabilia q.s. ad solutionem pro 0.5 ml pro vitro. - chronische hepatitis c - biotechnologika

PegIntron Pen 80 Mikrogramm Injektionspräparat Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

pegintron pen 80 mikrogramm injektionspräparat

msd merck sharp & dohme ag - peginterferonum alfa-2b - injektionspräparat - praeparatio cryodesiccata: peginterferonum alfa-2b 80 µg, dinatrii phosphas, natrii dihydrogenophosphas dihydricus, saccharum, polysorbatum 80. solvens: aqua ad iniectabilia q.s. ad solutionem pro 0.5 ml pro vitro. - chronische hepatitis c - biotechnologika

PegIntron Pen 100 Mikrogramm Injektionspräparat Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

pegintron pen 100 mikrogramm injektionspräparat

msd merck sharp & dohme ag - peginterferonum alfa-2b - injektionspräparat - praeparatio cryodesiccata: peginterferonum alfa-2b 100 µg, dinatrii phosphas, natrii dihydrogenophosphas dihydricus, saccharum, polysorbatum 80. solvens: aqua ad iniectabilia q.s. ad solutionem pro 0.5 ml pro vitro. - chronische hepatitis c - biotechnologika

PegIntron Pen 120 Mikrogramm Injektionspräparat Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

pegintron pen 120 mikrogramm injektionspräparat

msd merck sharp & dohme ag - peginterferonum alfa-2b - injektionspräparat - praeparatio cryodesiccata: peginterferonum alfa-2b 120 µg, dinatrii phosphas, natrii dihydrogenophosphas dihydricus, saccharum, polysorbatum 80. solvens: aqua ad iniectabilia q.s. ad suspensionem pro 0.5 ml pro vitro. - chronische hepatitis c - biotechnologika